B&A Therapeutics Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
B&A Therapeutics General Information
Description
Developer of novel therapies intended to treat neurological diseases. The company develops medicines for neurological and neurodegenerative diseases such as Parkinson's and Huntington's, enabling healthcare providers to have access to new medicines to treat patients.
Contact Information
Website
www.batherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Batiment Beret-Delaage, Zone Luminy Biotech
- Case 922, 163 Avenue de Luminy, cedex 09
- 13288 Marsheille
- France
+33 04 00 00 00 00
B&A Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
B&A Therapeutics Executive Team (9)
B&A Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator | 000 0000 | 000000 0 |